Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs

BACKGROUND: Vaccination confers relatively short-term protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), indicating the need for booster doses. Immunocompromised individuals, including those with immune-mediated inflammatory diseases (IMIDs), may have pronounced immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Smetanova, Jitka, Milota, Tomas, Rataj, Michal, Hurnakova, Jana, Zelena, Hana, Sediva, Anna, Horvath, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538326/
https://www.ncbi.nlm.nih.gov/pubmed/36211417
http://dx.doi.org/10.3389/fimmu.2022.1010808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538326/
https://www.ncbi.nlm.nih.gov/pubmed/36211417
http://dx.doi.org/10.3389/fimmu.2022.1010808

Ejemplares similares